Perla i

Julie A. Gelms, RN, BSN, PA-C
Degrees: Physician Assistant/Associates of Liberal Arts and Science Graduate Studies/ Research in Clinical Psychology and Bereavement Degree: BSN, Bachelors of Science in Nursing .

The Center for Hematology-Oncology/Boca Raton Community
Hospital, Inc.
6282 Linton Blvd. Delray Beach, FL,33484 / 701 NW 13th Street, Boca Raton,
FL33486, /7593 Boynton Beach Blvd. Boynton Beach, FL 33437/800 Meadows
Road Boca Raton, FL 33486
Physician Assistant-Hematology/Oncology Clinical Responsibilities: Outpatient clinical management of Hematology- Oncology Patients 2005-2006 Private
Consultant to local start up company developing home based surveillance and monitoring system for homebound chronically ill elderly Patients
2000- 2005
University of Chicago Hospital, Chicago, IL
Senior Physician Assistant: Bone Marrow Transplant Team Clinical Responsibilities:
Inpatient and Outpatient clinical management of Stem Cell Academic Responsibilities:
Preceptor to Clinical Oncology rotation students at University of Chicago Author/Monitor of written guidelines for the University of Chicago 2005 Procedures:

Team Member:
Patient Education Committee on Stem Cell Transplant Unit Christ Hospital and Medical Center, Oak Lawn, IL
Medical Oncology RN
Clinical Responsibilities:
Provided inpatient and outpatient primary care
Chemotherapy Administration/Venous access maintenance
Team Member:
Interdisciplinary team member Narcotic Task Force Committee Facilitate support group sessions and provide patient and family teaching

Artz, N. Dieterle, J.Gelms, S. Parsad, R. Larson, W. Stock, C.
Daugherty, T. Zimmerman, O. Odenike, S. Smith, K.Van Besien. Valacyclovir compared to Acyclovir for cytomegalovirus prophylaxis in allogeneic stem cell transplant recipients. (Poster, presented at IBMTR, 2003) Hacker, E. D., Ferrans, C. E., Verlen, E., Ravandi, F., Van Besien, K.,
Gelms, J., & Dieterle, N. (in press). Fatigue and Physical Activity in
Patients Receiving Hematopoeitic Stem Cell Transplantation. Oncology
Nursing Forum. (Published May 2006)
Koen Van Besien, Sonali Smith, Olatoyoyosi Odenike, Chris Daugherty,
Todd Zimmerman, Michael Thirman, Demetria Collins-Jones, Diane
Switzer, Nathalie Dieterle, Julie Gelms, Dorie Sher, Richard Larson,
Amittha Wickrema, Wendy Stock section of Hematology/Oncology,
University of Chicago, Chicago IL, USA2611 Alemtuzumab (Campath)
Based GVHD Prophylaxis Leads to Improved Survival after Allogeneic
Transplantation for Patients with Advanced Hematologic Malignancies.
Session Type: Poster Session 782-II
Specialized international examiner training of patients involved in a Phase II Randomized single blinded study of Extracorporeal Photoimmune (ECP) therapy in conjunction with standard therapy compared to standard therapy alone in patients with steroid refractory Graft versus Host Disease of the skin. Phi Theta Kappa Honor Society Member 1997-1999


Cg00200 aptt ellagic acid

APTT ELLAGIC ACID Valuation of activated Partial Thromboplastin Time (APTT) in plasma use manual and automatic procedure TEST SUMMARY The contact system is activated by the ellagic acid. • As with any diagnostic procedure, if the results are The cephalic extracted from bovine brain take effect as inconsistent with the clinical presentation, the substitute for PF3. The clot form

Grandes manoeuvres dans la pharmacie américaine LE MONDE | 10.03.09 | 10h18 • Mis à jour le 10.03.09 | 11h58Six semaines après le rachat du laboratoire américain Wyeth par son compatriote Pfizer pour 68 mil iards de dol ars, une autre opération géante vient rebattre les cartes du secteur pharmaceutique. Merck a annoncé, lundi 9 mars, l'acquisition de Schering-Plough pour 41,1 mil iard

Copyright © 2010-2014 Metabolize Drugs Pdf